CA 27-29

CA 27-29 is a tumor marker for breast cancer.[1]

It is a form of glycoprotein MUC1.[2]

References

"Definition of CA 27-29. From MedicineNet. Last Editorial Review: 6/14/2012".
"CA 27-29 in patients with breast cancer with pulmonary fibrosis". Clin Breast Cancer. 8: 538–40. Dec 2008. doi:10.3816/CBC.2008.n.067. PMID 19073511.

Blood

Lymphoma	Neprilysin
Lymphosarcoma	CD3 CD79a

Endocrine

Thyroid cancer	Thyroglobulin Medullary thyroid cancer (Calcitonin Carcinoembryonic antigen)
Pheochromocytoma	Normetanephrine Enolase 2
Neuroendocrine tumors	Synaptophysin Chromogranin A
Neuroblastoma	Homovanillic acid

Nervous system

Brain tumor	PCNA
Astrocytoma	Glial fibrillary acidic protein
NC/Melanoma	S100 protein Melanoma inhibitory activity

Cardiovascular/
respiratory

Lung cancer	Carcinoembryonic antigen Enolase 2 Autocrine motility factor
Hemangiosarcoma (endothelium)	Factor VIII

Digestive

Colorectal cancer	CA19-9 Carcinoembryonic antigen
Pancreatic cancer	CA19-9 Carcinoembryonic antigen CA 242 Tumor-associated glycoprotein 72
Hepatocellular carcinoma	Alpha-fetoprotein/AFP-L3

Reproductive/
urinary/
breast

Ovarian tumor	Surface epithelial-stromal tumor CA-125 EC CD30 hCG EST Alpha-fetoprotein Choriocarcinoma hCG Dysgerminoma LDH Sertoli-Leydig cell tumour Testosterone GCT Inhibin
Testicular cancer	βhCG Alpha-fetoprotein/AFP-L3 CD30
Prostate cancer	Prostate-specific antigen Prostatic acid phosphatase Glutamate carboxypeptidase II erbB-3 receptor Early prostate cancer antigen-2 SPINK1 GOLM1 PCA3 TMPRSS2
Germ cell tumor	NANOG
Bladder cancer	erbB-3 receptor NMP22
Breast cancer	CA 15-3 erbB-2 receptor erbB-3 receptor Cathepsin D CA 27-29

General histology

Sarcoma	Vimentin
Carcinoma (epithelium)	Cytokeratin

Musculoskeletal

Rhabdomyosarcoma	Desmin

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.